George C. Prendergast PhD

George C. Prendergast, Ph.D. was appointed the President and CEO of the Lankenau Institute for Medical Research (LIMR) in December 2004. Prendergast is a graduate of the University of Pennsylvania, whereas Benjamin Franklin Scholar earned a bachelor's degree magna cum laude with distinction in biochemistry. He received his master’s degree in molecular biophysics and biochemistry from Yale University and his doctorate in molecular biology from Princeton University.

After obtaining advanced training as an American Cancer Society postdoctoral fellow at the Howard Hughes Medical Institute at NYU Medical Center, he joined the department of cancer research at Merck Research Laboratories. In 1993, Prendergast was appointed assistant professor and later associate professor at The Wistar Institute in Philadelphia, where he was designated a pew scholar in the Biomedical Sciences. Subsequently, he became the senior director of the Cancer Research Group at the DuPont Pharmaceutical Company.